Warby Parker CEO Blumenthal sells $1.25 million in shares

Warby Parker (WRBY) reported mixed second-quarter 2025 results, with revenue of $214.5 million exceeding forecasts and EBITDA beating guidance by 14%, despite a $0.01 loss per share that missed expectations. Concurrently, Co-CEO Neil Harris Blumenthal completed a pre-planned sale of 50,000 Class A shares for $1.25 million, offset by a Class B conversion, while maintaining significant equity. Analyst sentiment remains varied, with some firms like BTIG raising price targets and maintaining 'Buy' ratings, citing general and administrative expense leverage as a key factor in the company's outlook.

Analysis

Warby Parker (WRBY) presented a mixed financial picture in its second-quarter 2025 results, characterized by strong top-line performance offset by a bottom-line shortfall. The company's revenue grew to $214.5 million, surpassing both analyst forecasts of $212.94 million and the high end of its own guidance. Furthermore, EBITDA exceeded guidance by a notable $3 million, a 14% beat, indicating robust operational efficiency. However, these strengths were contrasted by a reported loss per share of $0.01, which was a significant miss against the consensus expectation of a $0.08 profit, constituting a 112.5% negative surprise. Fundamentally, the company remains on solid footing with a current ratio of 2.55 and a strong cash position relative to its debt. On the corporate governance front, the Co-CEO's sale of 50,000 shares, valued at approximately $1.26 million, is significantly mitigated by the fact that it was executed under a pre-disclosed Rule 10b5-1 trading plan and was accompanied by a simultaneous conversion of an equal number of Class B shares, with the executive retaining a substantial equity stake. Analyst sentiment reflects this mixed data, with BTIG issuing a 'Buy' rating and a price target increase to $28.00 based on G&A leverage potential, while Stifel and Citizens JMP maintained more neutral 'Hold' and 'Market Perform' ratings, respectively.

Key Decisions for Investors

• Investors should weigh the company's strong revenue performance, 14% EBITDA beat, and healthy balance sheet against the significant second-quarter earnings per share miss.
• The Co-CEO's stock sale should be considered in the context of a pre-planned trading schedule and an offsetting share conversion, which lessens its significance as a bearish signal.
• Given the divergent analyst ratings, monitoring the company's ability to leverage SG&A expenses and sustain new customer acquisition will be critical, as these are the key drivers behind the more bullish price target revisions.